Authors: CHAUFOUR S LECOZ F DENOLLE T DUBRUC C CIMAROSTI I DESCHAMPS C ULLIAC N DELHOTALLANDES B ROSENZWEIG P

Citation: S. Chaufour et al., LACK OF EFFECT OF MIZOLASTINE ON THE SAFETY AND PHARMACOKINETICS OF DIGOXIN ADMINISTERED ORALLY IN REPEATED DOSES TO HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 286-291

Authors: ROSENZWEIG P CAPLAIN H CHAUFOUR S ULLIAC N CABANIS MJ THEBAULT JJ

Citation: P. Rosenzweig et al., COMPARATIVE WHEAL AND FLARE STUDY OF MIZOLASTINE VS TERFENADINE, CETIRIZINE, LORATADINE AND PLACEBO IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 40(5), 1995, pp. 459-465

Authors: PATAT A PERAULT MC VANDEL B ULLIAC N ZIELENIUK I ROSENZWEIG P

Citation: A. Patat et al., LACK OF INTERACTION BETWEEN A NEW ANTIHISTAMINE, MIZOLASTINE, AND LORAZEPAM ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39(1), 1995, pp. 31-38

Authors: PATAT A STUBBS D DUNMORE C ULLIAC N SEXTON B ZIELENIUK I IRVING A JONES W

Citation: A. Patat et al., LACK OF INTERACTION BETWEEN 2 ANTIHISTAMINES, MIZOLASTINE AND CETIRIZINE, AND ETHANOL IN PSYCHOMOTOR AND DRIVING PERFORMANCE IN HEALTHY-SUBJECTS, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 143-150

Authors: PINQUIER JL MICHEL L CABANIS MJ DUBRUC C ULLIAC N ROSENZWEIG P DUBERTRET L

Citation: Jl. Pinquier et al., EFFECT OF MIZOLASTINE ON EXPERIMENTAL INFLAMMATION IN HUMAN SKIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 169-169

Authors: ROSENZWEIG P CABANIS MJ DUBRUC C ULLIAC N THEBAULT JJ

Citation: P. Rosenzweig et al., PHARMACOKINETICS PHARMACODYNAMICS (PK-PD) RELATIONSHIPS OF MIZOLASTINE, A NEW NON SEDATIVE H-1 ANTIHISTAMINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 170-170